Welcome to Betalin
+972 (52) 395 9796
david@betalintherapeutics.com
Betalin - Logo
  • Home
  • Science
  • BetalinUK
  • News
  • Team
  • Collaborators
  • Contact
betalin therapeutics

REVOLUTIONIZING DIABETES TREATMENT

Revolutionizing diabetes treatment. Betalin is currently carrying pre-clinical studies and in discussions with both the Human Tissue Association (UK) and Food Drug Association (US) to begin clinical trials. 

Learn More
Play Video

BETALIN'S STORY

Betalin Therapeutics licensed the novel Engineered Micro Pancreas (EMP) technology developed at The Hebrew University of Jerusalem, Israel, in an exclusive worldwide agreement in 2015. The Hebrew University continues to partner with Betalin Therapeutics to support the research and development.

The EMP aims to restore normal blood glucose levels by mimicking the function of
the pancreas using islet cells encapsulated within a micro-organ matrix scaffold. Betalin has produced some promising results and we hope to submit a package soon to the HTA to begin our first in-man studies.

WHAT IS DIABETES?

When you eat, your food is broken down into glucose (sugar), this in turn increases you blood glucose levels. Insulin is a hormone and is released from the beta cells in the islet cells of your pancreas. Insulin helps facilitate the glucose into our cells from the blood, decreasing blood glucoses levels and either provides cells with energy or stores it for later use.  

Diabetes is a disease in which the body cannot regulated blood glucose levels efficiently due to insulin abnormalities. Diabetes is spilt into an umbrella of types, the most prevalent being type I diabetes (where your body doesn’t produce insulin) and type II diabetes (when you don’t produce a sufficient amount of insulin).

Healthy Individual

  • Can self regulate blood glucose
  • Doesn’t need to count carbohydrates

Type I Diabetic

  • Requires to take insulin injection daily
  • Accounts for 8% of all cases 

Type II Diabetic 

  • Can be treated through lifestyle changes, oral medication and insulin
  • Accounts for 90% of all cases

Having diabetes requires constant daily monitoring to keep blood glucose in range

Uncontrolled diabetes can lead to serious health complication such as blindness, amputation and cardiovascular problems

The Global cost of diabetes and its related illnesses is set to double by 2030 to $2.5 trillion

A cure would not only improve the quality of lives of those suffering but will also help alleviate health related cost

BETALIN'S PIPELINE

EMP1

  • The first generation of the EMP to regulate blood glucose levels by insulin secretion
  • It is implanted under a simple local anaesthetic procedure decreasing complications comparatively to other transplantation methods
  • The EMP will be be used for the clinical market

Funded by: 

EMP1R

  • The EMP1R is for the research market. It will be used as a tool to improve diabetic drug screening by accelerating the drug discovery market and reducing development costs and testing
  • Click here to find out more

Partially funded by:

β-EMP

  • This is the second generation of EMP, a product based on the MOM incorporated with stem cells-derived beta cells. The use of β-cells derived from stem cells, will eliminate the need for human pancreatic donors and expand Betalin’s market considerably

Partially funded by:


Using the state of the art technology, this next generation of treatment has been fully supported by experts in this field

AWARDS

BEST PHARMACEUTICAL STARTUP

Mixiii International Competition (Tel Aviv, Israel)

MOST PROMISING STARTUP

Xi'an International Entrepreneurship Competition (Xi’an, China)

FIRST PLACE

Chengdu International Innovation and Entrepreneurship Competition (London Stop)

Chengdu International Innovation and Entrepreneurship Competition - October 28 - 29 - 2019

FIRST PLACE

THE 3RD CHINA-ISRAEL INNOVATION AND ENTREPRENEURSHIP CONTEST SEMIFINAL FOR LIFE SCIENCE GROUP

We are Hiring!

At Betalin we’re passionate about our mission to cure diabetes and as the company continues to grow, we will expand our team of researchers and business developers. If you believe you’d make a good addition to our team, we invite you to submit your resume.

joIN OUR TEAM
© Betalin Therapeutics Ltd. All Rights Reserved
Betalin Therapeutics Ltd. is a preclinical stage company.
Betalin Therapeutics' products are not currently available for human use.